Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pulmatrix (PULM)
NASDAQ:PULM
Holding PULM?
Track your performance easily
PULM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.55 - $2.75
Previous Close$2.18
Volume5.62K
Average Volume (3M)12.47K
Market Cap
$7.96M
Enterprise Value-$4.39M
Total Cash (Recent Filing)$12.38M
Total Debt (Recent Filing)$24.00K
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Nov 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.97
Shares Outstanding3,652,285
10 Day Avg. Volume14,959
30 Day Avg. Volume12,471
Standard Deviation0.19
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.58
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.39
Enterprise Value/Gross Profit-0.60
Enterprise Value/Ebitda0.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pulmatrix News
PremiumCompany Announcements
Pulmatrix Announces Executive Changes and New Interim CEO
PremiumCompany Announcements
Pulmatrix Publishes Study on Inhalable Migraine TreatmentRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PULM FAQ
What was Pulmatrix’s price range in the past 12 months?
Pulmatrix lowest stock price was $1.55 and its highest was $2.75 in the past 12 months.
What is Pulmatrix’s market cap?
Currently, no data Available
When is Pulmatrix’s upcoming earnings report date?
Pulmatrix’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Pulmatrix’s earnings last quarter?
Pulmatrix released its earnings results on Aug 13, 2024. The company reported -$1.59 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.59.
Is Pulmatrix overvalued?
According to Wall Street analysts Pulmatrix’s price is currently Overvalued.
Does Pulmatrix pay dividends?
Pulmatrix does not currently pay dividends.
What is Pulmatrix’s EPS estimate?
Pulmatrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulmatrix have?
Pulmatrix has 3,652,285 shares outstanding.
What happened to Pulmatrix’s price movement after its last earnings report?
Pulmatrix reported an EPS of -$1.59 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.803%.
Which hedge fund is a major shareholder of Pulmatrix?
Currently, no hedge funds are holding shares in PULM
---
Pulmatrix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.80%
12-Months-Change
Fundamentals
Return on Equity
-58.99%
Trailing 12-Months
Asset Growth
-49.73%
Trailing 12-Months
Company Description
Pulmatrix
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.
---
PULM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering PULM
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-20.13%
reiterated a buy rating 10 months ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -20.13% per trade.
---